Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ORIC

Oric Pharmaceuticals (ORIC)

Oric Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORIC
DateTimeSourceHeadlineSymbolCompany
07/05/202406:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORICOric Pharmaceuticals Inc
07/05/202406:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
07/05/202406:05GlobeNewswire Inc.ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational UpdatesNASDAQ:ORICOric Pharmaceuticals Inc
04/05/202406:30GlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
16/04/202406:15GlobeNewswire Inc.ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLCNASDAQ:ORICOric Pharmaceuticals Inc
08/04/202422:00GlobeNewswire Inc.ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:ORICOric Pharmaceuticals Inc
06/04/202407:30GlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
05/04/202407:30GlobeNewswire Inc.ORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ORICOric Pharmaceuticals Inc
12/03/202408:28Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ORICOric Pharmaceuticals Inc
12/03/202407:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORICOric Pharmaceuticals Inc
12/03/202407:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
12/03/202407:05GlobeNewswire Inc.ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational UpdatesNASDAQ:ORICOric Pharmaceuticals Inc
07/03/202408:30GlobeNewswire Inc.ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceNASDAQ:ORICOric Pharmaceuticals Inc
06/03/202408:30GlobeNewswire Inc.ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:ORICOric Pharmaceuticals Inc
02/03/202408:30GlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
15/02/202408:30GlobeNewswire Inc.ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership SummitNASDAQ:ORICOric Pharmaceuticals Inc
05/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORICOric Pharmaceuticals Inc
03/02/202408:30GlobeNewswire Inc.ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ORICOric Pharmaceuticals Inc
01/02/202408:30GlobeNewswire Inc.ORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ORICOric Pharmaceuticals Inc
31/01/202404:12Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ORICOric Pharmaceuticals Inc
27/01/202408:58Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORICOric Pharmaceuticals Inc
26/01/202405:24Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ORICOric Pharmaceuticals Inc
23/01/202401:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
23/01/202400:30GlobeNewswire Inc.ORIC Pharmaceuticals Announces $125 Million Private Placement FinancingNASDAQ:ORICOric Pharmaceuticals Inc
10/01/202401:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
09/01/202400:30GlobeNewswire Inc.ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming MilestonesNASDAQ:ORICOric Pharmaceuticals Inc
03/01/202408:30GlobeNewswire Inc.ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ORICOric Pharmaceuticals Inc
29/12/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ORICOric Pharmaceuticals Inc
16/12/202308:32Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ORICOric Pharmaceuticals Inc
12/12/202308:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORICOric Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORIC